Skip to main content
. 2022 Nov 2;57(Suppl 1):100–416. doi: 10.1038/s41409-022-01798-0
Patient Malignancy Conditioning regimen Donor Symptomatic infection BK virus level (copies/mL) initial Week 1 Week 2 Week 3
1 Pre B-ALL MA CY/TBI + r ATG MUD D 38 4.00E + 08 2.70E + 08 1.20E + 08 0
2 T-Cell lymphoma RI BU/FLU MRD D 35 9.60E + 07 1.40E + 07 1,700,000 35,800
3 Mixed phenotype AML RI BU/FLU MRD D 31 3.50E + 08 210,000 0 N/A
4 AML MA BU/FLU MUD D 40 6.50E + 08 2.0E + 08 1,500,000 10,000
5 T-ALL MA CY/TBI MRD D 32 4.90E + 08 180,000 20.000 0